These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30841449)

  • 41. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
    Qin J; Luo M; Qian H; Chen W
    Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1.
    Garten A; Grohmann T; Kluckova K; Lavery GG; Kiess W; Penke M
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Berberine induces selective apoptosis through the AMPK‑mediated mitochondrial/caspase pathway in hepatocellular carcinoma.
    Yang X; Huang N
    Mol Med Rep; 2013 Aug; 8(2):505-10. PubMed ID: 23732865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for a direct cross-talk between malic enzyme and the pentose phosphate pathway via structural interactions.
    Yao P; Sun H; Xu C; Chen T; Zou B; Jiang P; Du W
    J Biol Chem; 2017 Oct; 292(41):17113-17120. PubMed ID: 28848047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.
    Chen HC; Jeng YM; Yuan RH; Hsu HC; Chen YL
    Ann Surg Oncol; 2012 Jun; 19(6):2011-9. PubMed ID: 22146883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway.
    Huang GM; Jiang QH; Cai C; Qu M; Shen W
    Cancer Lett; 2015 Mar; 358(2):180-190. PubMed ID: 25528629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells.
    Kim JO; Kim KH; Song IS; Cheon KS; Kim OH; Lee SC; Lee SK; Kim SJ
    Oncotarget; 2017 Jan; 8(2):2936-2948. PubMed ID: 27935857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.
    Park SY; Han J; Kim JB; Yang MG; Kim YJ; Lim HJ; An SY; Kim JH
    Eur J Cancer; 2014 Jan; 50(2):341-50. PubMed ID: 24161763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin.
    Gao M; Kong Q; Hua H; Yin Y; Wang J; Luo T; Jiang Y
    Oncotarget; 2016 Mar; 7(13):16349-61. PubMed ID: 26918349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells.
    Lee CW; Wong LL; Tse EY; Liu HF; Leong VY; Lee JM; Hardie DG; Ng IO; Ching YP
    Cancer Res; 2012 Sep; 72(17):4394-404. PubMed ID: 22728651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenine inhibits growth of hepatocellular carcinoma cells via AMPK-mediated S phase arrest and apoptotic cascade.
    Su WW; Huang JY; Chen HM; Lin JT; Kao SH
    Int J Med Sci; 2020; 17(5):678-684. PubMed ID: 32210718
    [No Abstract]   [Full Text] [Related]  

  • 52. Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma.
    Wang Y; Su K; Wang C; Deng T; Liu X; Sun S; Jiang Y; Zhang C; Xing B; Du X
    Cell Death Dis; 2024 Jul; 15(7):545. PubMed ID: 39085201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib.
    Liu Y; Lou G; Norton JT; Wang C; Kandela I; Tang S; Shank NI; Gupta P; Huang M; Avram MJ; Green R; Mazar A; Appella D; Chen Z; Huang S
    FASEB J; 2017 Dec; 31(12):5453-5465. PubMed ID: 28821631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sorafenib and 2-Deoxyglucose Synergistically Inhibit Proliferation of Both Sorafenib-Sensitive and -Resistant HCC Cells by Inhibiting ATP Production.
    Reyes R; Wani NA; Ghoshal K; Jacob ST; Motiwala T
    Gene Expr; 2017 Feb; 17(2):129-140. PubMed ID: 27938509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ICMT contributes to hepatocellular carcinoma growth, survival, migration and chemoresistance via multiple oncogenic pathways.
    Xu J; Zhu Y; Wang F; Zhou Y; Xia G; Xu W
    Biochem Biophys Res Commun; 2019 Oct; 518(3):584-589. PubMed ID: 31451223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma.
    Wang L; Li H; Zhen Z; Ma X; Yu W; Zeng H; Li L
    Gene; 2019 Mar; 690():129-136. PubMed ID: 30597237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC.
    Kim MJ; Choi YK; Park SY; Jang SY; Lee JY; Ham HJ; Kim BG; Jeon HJ; Kim JH; Kim JG; Lee IK; Park KG
    Mol Cancer Res; 2017 Sep; 15(9):1230-1242. PubMed ID: 28584024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
    Liu Y; Sun L; Su X; Guo S
    Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BNIP3-mediated mitophagy boosts the competitive growth of Lenvatinib-resistant cells via energy metabolism reprogramming in HCC.
    Wang S; Cheng H; Li M; Gao D; Wu H; Zhang S; Huang Y; Guo K
    Cell Death Dis; 2024 Jul; 15(7):484. PubMed ID: 38969639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.